Johnson & Johnson Shares Rise on Reported Talks with Apollo for Orthopedics Unit
Johnson & Johnson (NYSE:JNJ) shares rose in pre-market trading following reports that Apollo Global Management is discussing the potential acquisition of its orthopedics business. Bloomberg cited unnamed sources indicating a possible $20 billion valuation and an agreement potentially reached within weeks, though no official confirmation was provided. The orthopedics unit generated $9.3 billion in revenue in 2025 but has faced numerous lawsuits over hip replacement devices. Investors are evaluating the potential transaction's impact on Johnson & Johnson’s stock value.
Topics: Apollo Global Management Johnson & Johnson Orthopedics Unit Stock Movement